2022
DOI: 10.1016/j.hroo.2022.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Atrial CARdiac Magnetic resonance imaging in patients with embolic stroke of unknown source without documented Atrial Fibrillation (CARM-AF): Study design and clinical protocol

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…47 A recently published protocol for a prospective multicenter CARM-AF study will aim to identify patients with ESUS at risk of future thromboembolism due to atrial cardiomyopathy through non-invasive CMR and ECG data. 48 The unparalleled soft-tissue contrast and robust temporal resolution of CMR allow reliable detection and characterization of a variety of LV embolic sources (Figure 4(b) to (d)). CMR can accurately detect LV thrombi, which appear markedly hypointense on early and delayed enhancement images, 49 and reliably differentiate them from tumors and other cardiac masses (Figure 4(d)).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…47 A recently published protocol for a prospective multicenter CARM-AF study will aim to identify patients with ESUS at risk of future thromboembolism due to atrial cardiomyopathy through non-invasive CMR and ECG data. 48 The unparalleled soft-tissue contrast and robust temporal resolution of CMR allow reliable detection and characterization of a variety of LV embolic sources (Figure 4(b) to (d)). CMR can accurately detect LV thrombi, which appear markedly hypointense on early and delayed enhancement images, 49 and reliably differentiate them from tumors and other cardiac masses (Figure 4(d)).…”
Section: Discussionmentioning
confidence: 99%
“…47 A recently published protocol for a prospective multicenter CARM-AF study will aim to identify patients with ESUS at risk of future thromboembolism due to atrial cardiomyopathy through non-invasive CMR and ECG data. 48…”
Section: Discussionmentioning
confidence: 99%
“…The full study design has been previously published. 12 Ethical approval was granted by Health Research Authorities and the South London Research Ethics Committee (REC: 19//LO/1933). The study conforms to the principles outlined in the Declaration of Helsinki.…”
Section: Methodsmentioning
confidence: 99%